FDA label
What is Jantoven used for?
Jantoven contains warfarin. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “JANTOVEN ®is indicated for: Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE); Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement; Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myo...”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Jantoven?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Jantoven, tablet
Indications and Usage, quoted from the label by Upsher-Smith Laboratories, LLC (ANDA040416). Cross-references to other label sections are left out.
JANTOVEN ®is indicated for:
- Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE).
- Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement.
- Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
Limitations of Use
Warfarin Sodium has no direct effect on an established thrombus, nor does it reverse ischemic tissue damage. Once a thrombus has occurred, however, the goals of anticoagulant treatment are to prevent further extension of the formed clot and to prevent secondary thromboembolic complications that may result in serious and possibly fatal sequelae.
Source: DailyMed label, set id 19a69a72-ac5d-45d5-a94d-a5aaecbe4730, version 13, effective July 8, 2025. NDC 0832-1211, one of 9 listings for this product.
Questions
What is Jantoven used for?
The FDA label says: “JANTOVEN ®is indicated for: Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE); Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement; Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myo...”
What drug class is Jantoven?
FDA lists warfarin in the Vitamin K Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Jantoven
- Is Jantoven a controlled substance?Federal schedule
- What is Warfarin used for?FDA label uses
- Is Warfarin a controlled substance?Federal schedule
- Generic for CoumadinFDA Orange Book
- Generic for AthrombinFDA Orange Book
- Generic for PanwarfinFDA Orange Book
- Vitamin K Antagonists listFDA drug class
- NDC 0832-1211Jantoven NDC record
- NDC 0832-1212Jantoven NDC record
- NDC 0832-1213Jantoven NDC record